China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Japanese drugmaker Shionogi and US pharma major Eli Lilly were among the big spenders in pharma M&A during May.

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Pharmageddon,' a documentary directed by Donal O'Neill and produced by cardiologist Aseem Malhotra, was launched recently at ...